APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Laboratory-developed Testing

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.

LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.

While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.

Selected research

Market Outlook & Growth Opportunities

Global Laboratory-developed Testing Market Outlook and Growth Opportunities 2026

Report ID 173894580425 December 2025192 pages

Choose your research edition.

Industry ResearchLaboratory-developed Testing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Laboratory-developed Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Laboratory-developed Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laboratory-developed Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Laboratory-developed Testing Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.

LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.

Read the full market overview

While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.

The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.

North America is the largest market with more than 65% of the market, followed by Europe with about 15%.

This report provides an overview of the global Laboratory-developed Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laboratory-developed Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laboratory-developed Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Laboratory-developed Testing market.

Laboratory-developed Testing Segment by Company

Adaptive Biotechnologies Corporation

Quest Diagnostics

Roche

Illumina

Qiagen

Eurofins

Guardant Health

Biotheranostics

Adaptive Biotechnologies

Rosetta Genomics

Biodesix

Helix

Laboratory-developed Testing Segment by Type

Commercial Service

R&D

Laboratory-developed Testing Segment by Application

Genetic Testing

Oncology

Infectious Disease

Others

Laboratory-developed Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Laboratory-developed Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Laboratory-developed Testing key companies, revenue, market share, and recent developments.

3. To split the Laboratory-developed Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Laboratory-developed Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laboratory-developed Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Laboratory-developed Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory-developed Testing industry.

Chapter 3: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Laboratory-developed Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Laboratory-developed Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laboratory-developed Testing Industry Trends Table 2. Laboratory-developed Testing Industry Drivers Table 3. Laboratory-developed Testing Industry Opportunities and Challenges Table 4. Laboratory-developed Testing Industry Restraints Table 5. Global Laboratory-developed Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laboratory-developed Testing Revenue Share by Company (2021-2026) Table 7. Global Laboratory-developed Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Laboratory-developed Testing Key Company Manufacturing Base & Headquarters Table 9. Global Laboratory-developed Testing Company, Product Type & Application Table 10. Global Laboratory-developed Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Laboratory-developed Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Commercial Service Table 15. Significant Companies of R&D Table 16. Global Laboratory-developed Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Laboratory-developed Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Laboratory-developed Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Laboratory-developed Testing Sales Value Share by Type (2021-2026) Table 20. Global Laboratory-developed Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Genetic Testing Table 22. Significant Companies of Oncology Table 23. Significant Companies of Infectious Disease Table 24. Significant Companies of Others Table 25. Global Laboratory-developed Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Laboratory-developed Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Laboratory-developed Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Laboratory-developed Testing Sales Value Share by Application (2021-2026) Table 29. Global Laboratory-developed Testing Sales Value Share by Application (2027-2032) Table 30. Global Laboratory-developed Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Laboratory-developed Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Laboratory-developed Testing Sales Value Share by Region (2021-2026) Table 33. Global Laboratory-developed Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Laboratory-developed Testing Sales Value Share by Region (2027-2032) Table 35. Global Laboratory-developed Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Laboratory-developed Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Laboratory-developed Testing Sales Value Market Share by Country (2021-2026) Table 38. Global Laboratory-developed Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Laboratory-developed Testing Sales Value Market Share by Country (2027-2032) Table 40. Adaptive Biotechnologies Corporation Company Information Table 41. Adaptive Biotechnologies Corporation Business Overview Table 42. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio Table 44. Adaptive Biotechnologies Corporation Recent Development Table 45. Quest Diagnostics Company Information Table 46. Quest Diagnostics Business Overview Table 47. Quest Diagnostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Quest Diagnostics Laboratory-developed Testing Product Portfolio Table 49. Quest Diagnostics Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Roche Laboratory-developed Testing Product Portfolio Table 54. Roche Recent Development Table 55. Illumina Company Information Table 56. Illumina Business Overview Table 57. Illumina Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Illumina Laboratory-developed Testing Product Portfolio Table 59. Illumina Recent Development Table 60. Qiagen Company Information Table 61. Qiagen Business Overview Table 62. Qiagen Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Qiagen Laboratory-developed Testing Product Portfolio Table 64. Qiagen Recent Development Table 65. Eurofins Company Information Table 66. Eurofins Business Overview Table 67. Eurofins Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Eurofins Laboratory-developed Testing Product Portfolio Table 69. Eurofins Recent Development Table 70. Guardant Health Company Information Table 71. Guardant Health Business Overview Table 72. Guardant Health Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Guardant Health Laboratory-developed Testing Product Portfolio Table 74. Guardant Health Recent Development Table 75. Biotheranostics Company Information Table 76. Biotheranostics Business Overview Table 77. Biotheranostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Biotheranostics Laboratory-developed Testing Product Portfolio Table 79. Biotheranostics Recent Development Table 80. Adaptive Biotechnologies Company Information Table 81. Adaptive Biotechnologies Business Overview Table 82. Adaptive Biotechnologies Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio Table 84. Adaptive Biotechnologies Recent Development Table 85. Rosetta Genomics Company Information Table 86. Rosetta Genomics Business Overview Table 87. Rosetta Genomics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Rosetta Genomics Laboratory-developed Testing Product Portfolio Table 89. Rosetta Genomics Recent Development Table 90. Biodesix Company Information Table 91. Biodesix Business Overview Table 92. Biodesix Laboratory-developed Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Biodesix Laboratory-developed Testing Product Portfolio Table 94. Biodesix Recent Development Table 95. Helix Company Information Table 96. Helix Business Overview Table 97. Helix Laboratory-developed Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Helix Laboratory-developed Testing Product Portfolio Table 99. Helix Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Laboratory-developed Testing Product Image Figure 2. Global Laboratory-developed Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laboratory-developed Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Laboratory-developed Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Commercial Service Image Figure 8. R&D Image Figure 9. Global Laboratory-developed Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Laboratory-developed Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Laboratory-developed Testing Sales Value Share by Type (2021-2032) Figure 12. Genetic Testing Image Figure 13. Oncology Image Figure 14. Infectious Disease Image Figure 15. Others Image Figure 16. Global Laboratory-developed Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Laboratory-developed Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Laboratory-developed Testing Sales Value Share by Application (2021-2032) Figure 19. Global Laboratory-developed Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Laboratory-developed Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Laboratory-developed Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America Laboratory-developed Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Laboratory-developed Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Laboratory-developed Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Laboratory-developed Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Laboratory-developed Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Laboratory-developed Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America Laboratory-developed Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Laboratory-developed Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Laboratory-developed Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Laboratory-developed Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Commercial Service
  • R&D
Applications
  • Genetic Testing
  • Oncology
  • Infectious Disease
  • Others
Companies covered
  • Adaptive Biotechnologies Corporation
  • Quest Diagnostics
  • Roche
  • Illumina
  • Qiagen
  • Eurofins
  • Guardant Health
  • Biotheranostics
  • Adaptive Biotechnologies
  • Rosetta Genomics
  • Biodesix
  • Helix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Laboratory-developed Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Laboratory-developed Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Laboratory-developed Testing Market Dynamics
  1. 2.1 Laboratory-developed Testing Industry Trends
  2. 2.2 Laboratory-developed Testing Industry Drivers
  3. 2.3 Laboratory-developed Testing Industry Opportunities and Challenges
  4. 2.4 Laboratory-developed Testing Industry Restraints
3 Laboratory-developed Testing Market by Company
  1. 3.1 Global Laboratory-developed Testing Company Revenue Ranking in 2025
  2. 3.2 Global Laboratory-developed Testing Revenue by Company (2021-2026)
  3. 3.3 Global Laboratory-developed Testing Company Ranking (2024-2026)
  4. 3.4 Global Laboratory-developed Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Laboratory-developed Testing Company Product Type and Application
  6. 3.6 Global Laboratory-developed Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Laboratory-developed Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Laboratory-developed Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Laboratory-developed Testing Market by Type
  1. 4.1 Laboratory-developed Testing Type Introduction
  2. 4.1.1 Commercial Service
  3. 4.1.2 R&D
  4. 4.2 Global Laboratory-developed Testing Sales Value by Type
  5. 4.2.1 Global Laboratory-developed Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Laboratory-developed Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Laboratory-developed Testing Sales Value Share by Type (2021-2032)
5 Laboratory-developed Testing Market by Application
  1. 5.1 Laboratory-developed Testing Application Introduction
  2. 5.1.1 Genetic Testing
  3. 5.1.2 Oncology
  4. 5.1.3 Infectious Disease
  5. 5.1.4 Others
  6. 5.2 Global Laboratory-developed Testing Sales Value by Application
  7. 5.2.1 Global Laboratory-developed Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Laboratory-developed Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Laboratory-developed Testing Sales Value Share by Application (2021-2032)
6 Laboratory-developed Testing Regional Value Analysis
  1. 6.1 Global Laboratory-developed Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laboratory-developed Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Laboratory-developed Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Laboratory-developed Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Laboratory-developed Testing Sales Value (2021-2032)
  7. 6.3.2 North America Laboratory-developed Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Laboratory-developed Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Laboratory-developed Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Laboratory-developed Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Laboratory-developed Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Laboratory-developed Testing Sales Value (2021-2032)
  16. 6.6.2 South America Laboratory-developed Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Laboratory-developed Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Laboratory-developed Testing Sales Value Share by Country, 2025 VS 2032
7 Laboratory-developed Testing Country-level Value Analysis
  1. 7.1 Global Laboratory-developed Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laboratory-developed Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Laboratory-developed Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Laboratory-developed Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Laboratory-developed Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Laboratory-developed Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Laboratory-developed Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Adaptive Biotechnologies Corporation
  2. 8.1.1 Adaptive Biotechnologies Corporation Company Information
  3. 8.1.2 Adaptive Biotechnologies Corporation Business Overview
  4. 8.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio
  6. 8.1.5 Adaptive Biotechnologies Corporation Recent Developments
  7. 8.2 Quest Diagnostics
  8. 8.2.1 Quest Diagnostics Company Information
  9. 8.2.2 Quest Diagnostics Business Overview
  10. 8.2.3 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Quest Diagnostics Laboratory-developed Testing Product Portfolio
  12. 8.2.5 Quest Diagnostics Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Laboratory-developed Testing Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Illumina
  20. 8.4.1 Illumina Company Information
  21. 8.4.2 Illumina Business Overview
  22. 8.4.3 Illumina Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Illumina Laboratory-developed Testing Product Portfolio
  24. 8.4.5 Illumina Recent Developments
  25. 8.5 Qiagen
  26. 8.5.1 Qiagen Company Information
  27. 8.5.2 Qiagen Business Overview
  28. 8.5.3 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qiagen Laboratory-developed Testing Product Portfolio
  30. 8.5.5 Qiagen Recent Developments
  31. 8.6 Eurofins
  32. 8.6.1 Eurofins Company Information
  33. 8.6.2 Eurofins Business Overview
  34. 8.6.3 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eurofins Laboratory-developed Testing Product Portfolio
  36. 8.6.5 Eurofins Recent Developments
  37. 8.7 Guardant Health
  38. 8.7.1 Guardant Health Company Information
  39. 8.7.2 Guardant Health Business Overview
  40. 8.7.3 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guardant Health Laboratory-developed Testing Product Portfolio
  42. 8.7.5 Guardant Health Recent Developments
  43. 8.8 Biotheranostics
  44. 8.8.1 Biotheranostics Company Information
  45. 8.8.2 Biotheranostics Business Overview
  46. 8.8.3 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biotheranostics Laboratory-developed Testing Product Portfolio
  48. 8.8.5 Biotheranostics Recent Developments
  49. 8.9 Adaptive Biotechnologies
  50. 8.9.1 Adaptive Biotechnologies Company Information
  51. 8.9.2 Adaptive Biotechnologies Business Overview
  52. 8.9.3 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio
  54. 8.9.5 Adaptive Biotechnologies Recent Developments
  55. 8.10 Rosetta Genomics
  56. 8.10.1 Rosetta Genomics Company Information
  57. 8.10.2 Rosetta Genomics Business Overview
  58. 8.10.3 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Rosetta Genomics Laboratory-developed Testing Product Portfolio
  60. 8.10.5 Rosetta Genomics Recent Developments
  61. 8.11 Biodesix
  62. 8.11.1 Biodesix Company Information
  63. 8.11.2 Biodesix Business Overview
  64. 8.11.3 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biodesix Laboratory-developed Testing Product Portfolio
  66. 8.11.5 Biodesix Recent Developments
  67. 8.12 Helix
  68. 8.12.1 Helix Company Information
  69. 8.12.2 Helix Business Overview
  70. 8.12.3 Helix Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Helix Laboratory-developed Testing Product Portfolio
  72. 8.12.5 Helix Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst